Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | OGN | Common Stock | Options Exercise | $0 | +5.96K | +28.59% | $0.00 | 26.8K | Mar 31, 2023 | Direct | |
transaction | OGN | Common Stock | Tax liability | -$48.8K | -2.12K | -7.88% | $23.09 | 24.7K | Mar 31, 2023 | Direct |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | OGN | Restricted Stock Units | Options Exercise | $0 | -5.96K | -33.33% | $0.00 | 11.9K | Mar 31, 2023 | Common Stock | 5.96K | Direct | F1, F2 | |
transaction | OGN | Restricted Stock Units | Award | $0 | +29.2K | $0.00 | 29.2K | Mar 31, 2023 | Common Stock | 29.2K | Direct | F3, F4 | ||
transaction | OGN | Stock Option (right to buy) | Award | $0 | +105K | $0.00 | 105K | Mar 31, 2023 | Common Stock | 105K | $23.52 | Direct | F5 |
Id | Content |
---|---|
F1 | Each Restricted Stock Unit converts into one share of Organon & Co. ("Organon") common stock. |
F2 | On March 31, 2023, one-third of the RSUs vested with the remaining RSUs to vest in two equal installments on March 31, 2024 and March 31, 2025. |
F3 | The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Organon common stock for each RSU. |
F4 | These RSUs vest and are distributed as shares of Organon common stock in three equal installments on March 31, 2024, March 31, 2025 and March 31, 2026. |
F5 | The Reporting Person was granted stock options, which vest and become exercisable in three equal installments on March 31, 2024, March 31, 2025 and March 31, 2026. |